Table 2 Cytogenetic findings in AML patients and their distribution according to risk stratification (n = 29)
Risk group according to cytogenetics | Cytogenetics | Number | Percentage (%) |
|---|---|---|---|
High risk group (n = 3) | Unfavorable cytogenetics | ||
inv.3 | 1 | 3.5 | |
t (6;9) | 2 | 6.9 | |
Intermediate risk group (n = 22) | Intermediate cytogenetics | ||
Cytogenetic abnormality not classified as adverse or favorable | 8 | 27.5 | |
Normal karyotype | 14 | 48.3 | |
Low risk group (n = 4) | Favorable cytogenetics | ||
t (8; 21) | 2 | 6.9 | |
t (15; 17) | 2 | 6.9 | |
Total | 29 | 100 |